These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 28204832)
1. Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells. Wang C; Guo L; Wang S; Wang J; Li Y; Dou Y; Wang R; Shi H; Ke Y; Liu H Int J Mol Med; 2017 Mar; 39(3):645-653. PubMed ID: 28204832 [TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line. Wang C; Guo LB; Ma JY; Li YM; Liu HM Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547 [TBL] [Abstract][Full Text] [Related]
3. Jesridonin in combination with paclitaxel demonstrates synergistic anti-tumor activity in human esophageal carcinoma cells. Wang C; Yang D; Jiang L; Wang S; Wang J; Zhou K; Shi X; Chang L; Liu Y; Ke Y; Liu H Bioorg Med Chem Lett; 2017 May; 27(9):2058-2062. PubMed ID: 28285918 [TBL] [Abstract][Full Text] [Related]
4. The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells. Wang C; Jiang L; Wang S; Shi H; Wang J; Wang R; Li Y; Dou Y; Liu Y; Hou G; Ke Y; Liu H PLoS One; 2015; 10(6):e0130284. PubMed ID: 26103161 [TBL] [Abstract][Full Text] [Related]
5. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817 [TBL] [Abstract][Full Text] [Related]
6. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma. Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264 [TBL] [Abstract][Full Text] [Related]
7. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506 [TBL] [Abstract][Full Text] [Related]
8. Xerophilusin B induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma cells and does not cause toxicity in nude mice. Yao R; Chen Z; Zhou C; Luo M; Shi X; Li J; Gao Y; Zhou F; Pu J; Sun H; He J J Nat Prod; 2015 Jan; 78(1):10-6. PubMed ID: 25555195 [TBL] [Abstract][Full Text] [Related]
9. Effects and mechanisms of FBXO31 on Taxol chemoresistance in esophageal squamous cell carcinoma. Lv L; Wang SC; Mo JY; Huang KL; Xu ML; Liu J Biochem Biophys Res Commun; 2022 Jan; 586():129-136. PubMed ID: 34839191 [TBL] [Abstract][Full Text] [Related]
10. Insights into anticancer activity and mechanism of action of a ruthenium(II) complex in human esophageal squamous carcinoma EC109 cells. Guo L; Lv G; Qiu L; Yang H; Zhang L; Yu H; Zou M; Lin J Eur J Pharmacol; 2016 Sep; 786():60-71. PubMed ID: 27262377 [TBL] [Abstract][Full Text] [Related]
11. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762. Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885 [TBL] [Abstract][Full Text] [Related]
12. Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells. Shi X; Qin T; Liu W; Zhang X; Li L; Huo J; Zhou K; Yang D; Zhang Y; Wang C Biomed Pharmacother; 2017 Dec; 96():1186-1192. PubMed ID: 29196102 [TBL] [Abstract][Full Text] [Related]
13. Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma. Wang J; Zhang Z; Che Y; Yuan Z; Lu Z; Li Y; Wan J; Sun H; Chen Z; Pu J; He J Cancer Chemother Pharmacol; 2018 Mar; 81(3):469-481. PubMed ID: 29308536 [TBL] [Abstract][Full Text] [Related]
14. Induction of the mitochondria-mediated apoptosis in human esophageal cancer cells by DS2, a newly synthetic diterpenoid analog, is regulated by Bax and caused by generation of reactive oxygen species. Ma YC; Ke Y; Zi X; Zhao F; Yuan L; Zhu YL; Fan XX; Zhao NM; Li QY; Qin YH; Liu HM Oncotarget; 2016 Dec; 7(52):86211-86224. PubMed ID: 27863415 [TBL] [Abstract][Full Text] [Related]
15. Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line. Shi X; Dou Y; Zhou K; Huo J; Yang T; Qin T; Liu W; Wang S; Yang D; Chang L; Wang C Biomed Pharmacother; 2017 Jun; 90():897-905. PubMed ID: 28441715 [TBL] [Abstract][Full Text] [Related]
16. JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo. Wang C; Wang R; Zhou K; Wang S; Wang J; Shi H; Dou Y; Yang D; Chang L; Shi X; Liu Y; Xu X; Zhang X; Ke Y; Liu H Cancer Chemother Pharmacol; 2016 Nov; 78(5):971-982. PubMed ID: 27620208 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio. Du L; Fei Z; Song S; Wei N Biomed Pharmacother; 2017 Nov; 95():447-452. PubMed ID: 28865364 [TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer]. Tang X; Lu M; Li C; Deng S; Li M Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734 [TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines. Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102 [TBL] [Abstract][Full Text] [Related]
20. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. Xie L; Song X; Yu J; Wei L; Song B; Wang X; Lv L J Exp Clin Cancer Res; 2009 May; 28(1):68. PubMed ID: 19470182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]